Novo Nordisk Urged by Sanders to Cut ‘Outrageous’ Ozempic Price

March 27, 2024, 7:06 PM UTC

“There is no rational reason, other than greed, for Novo Nordisk to charge Americans nearly $1,000 a month for Ozempic when it costs less than $5 to manufacture it and can be purchased in Germany for just $59,” Senate Health, Education, Labor and Pensions Chairman Bernie Sanders says on X.

  • Company “must substantially reduce the price of Ozempic in the US now,” Sanders says
  • NOTE: Ozempic, Wegovy Surge Puts Pressure on State Medicaid Plans

To contact the reporter on this story:
Maria Luiza Rabello in Washington at mrabello@bloomberg.net

To contact the editors responsible for this story:
Megan Howard ...











Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.